Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia

Fostamatinib demonstrated efficacy in phase 3 trials of adults with immune thrombocytopenia (ITP). Post hoc analysis compared patients who received fostamatinib as second‐line therapy (after steroids ± immunoglobulins) versus third‐or‐later‐line therapy (after ≥2 prior lines of therapy including a s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Haematol
Egile Nagusiak: Boccia, Ralph, Cooper, Nichola, Ghanima, Waleed, Boxer, Michael A, Hill, Quentin A., Sholzberg, Michelle, Tarantino, Michael D., Todd, Leslie K., Tong, Sandra, Bussel, James B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Platelets Haemostasis and Thrombosis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7540289/
https://ncbi.nlm.nih.gov/pubmed/33439486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16959
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak